Singapore O&G 1H 2020 results: The good and the bad

Singapore O&G (SOG) reported a decent set of 1H 2020 results despite the COVID-19 pandemic in Singapore. Revenue fell 4% to SGD17.8 million while net profit fell 21% to SGD3.7 million Here's the good and the bad about Singapore O&G results. Good Let's start with the good. Singapore O&G reinstated their dividend (0.5 cents). The … Continue reading Singapore O&G 1H 2020 results: The good and the bad

Portfolio news this week(ending 11 July)

This week's news includes Singapore's election results, TripAdvisor's bond issuance and increased competition for iFAST.Singapore elections, HRNet and Singapore O&G: Singapore's ruling party, the People Action Party (PAP) returned to power (83 out of 93 seats) but had one of the lowest share of the popular vote (61%) in its history. From Bloomberg:The result could … Continue reading Portfolio news this week(ending 11 July)

Portfolio news this week (ending 4 July)

KGI initiated research on Singapore O&G with a neutral rating because of downside risk to its dermatology business. Dermatology earnings are likely to be depressed this year but the value of a stock mainly comes from future earnings so I'm willing to be patient. Link TripAdvisor's CEO said in a Skift interview that the company … Continue reading Portfolio news this week (ending 4 July)

Portfolio news this week (ending 13 June)

Here's the top news this week affecting my positions in Singapore O&G, iFAST and TripAdvisor. TripAdvisor vs Booking: Booking.com will terminate existing contracts with attractions and tours and will create an experiences partnership with TUI's Musement instead. Booking.com users will eventually be directed to Musement's experiences.  Building an experiences business is clearly not easy when … Continue reading Portfolio news this week (ending 13 June)

Portfolio news this week (ending 6 June)

Here's the top news this week affecting my positions in Singapore O&G, iFAST and TripAdvisor. All Singapore O&G (SOG) services are available again: SOG clinics including their dermatology clinics can offer their full suite of services with Singapore's circuit breaker ending on 2 June. See the SOG poster below. However, competing dermatology clinics will be … Continue reading Portfolio news this week (ending 6 June)

Singapore O&G: 6 things to note in the 2019 annual report

Am I the only SOG shareholder who has given up looking at the share price?  Anyway, here's are six key highlights from their 2019 annual report. Let's start with the bad news: Dermatology impairment Increasing competition and weak medical tourism trends in Singapore resulted in a SGD11.3 million goodwill impairment for the year. Excluding the … Continue reading Singapore O&G: 6 things to note in the 2019 annual report

Zero sales test

How long can a company survive with zero revenue?  The COVID-19 crisis has forced governments to restrict movement so  restaurants, hotels and travel companies are faced with a grim scenario where revenue drops to zero. The cyclical companies in my portfolio such as China Aviation  Oil, TripAdvisor and HRNet are vulnerable but I subjected all … Continue reading Zero sales test

2019 year in review and most popular posts

This year was a tough year for my portfolio with 4 out of 6 stocks in the portfolio posting negative returns since I wrote about them.   Date purchased Start Now Dividend return (%) Capital return (%) Total return iFAST 22-Apr-18 0.92 1.03 7% 12% 19% Kingsmen 29-Apr-18 0.59 0.45 8% -24% -15% SOG 3-Jun-18 … Continue reading 2019 year in review and most popular posts

Portfolio review: Q3 2019 review

The five SGX companies in my portfolio reported mixed Q3 2019 results and their share prices have been depressed.These five companies should deliver growth in the future so I'm happy to hold these companies. iFAST and SOG has been the most consistent performers in terms of revenue and net profit growth and it's a painful … Continue reading Portfolio review: Q3 2019 review